Shares of GSK PLC GSK inched down 0.77% to £13.50 Thursday, on what proved to be an all-around positive trading session for ...
The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback